Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Rhone-Poulenc Rorer

This article was originally published in The Tan Sheet

Executive Summary

Rhone-Poulenc Rorer: Rhone-Poulenc increasing its ownership of RPR from 68.1% to 100% through a cash tender offer of $97 per share under a definitive agreement signed Aug. 19. The agreement stipulates that shares not acquired in the offer "will be acquired in a second step merger at the same price." The first tender offer will close when Rhone-Poulenc owns at least 90% of RPR's outstanding shares, the French parent company says. The tender offer will cost Rhone-Poulenc $4.37 bil. (27 bil. FFr)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel